Portfolio Holdings Detail for ISIN IE0003WV2ME7

Stock Name / Fund	iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
Issuer	Blackrock
Entity holding fund	iShares III Public Limited Company
Entity Type
Entity LEI	549300PZLRJB7M8H1057
ETF Ticker	ISPE(GBP) LSE
ETF Ticker	ISPE.L(GBP) LSE

Holdings detail for DXCM

Show aggregate DXCM holdings

News associated with DXCM

Implied QQEW Analyst Target Price: $156

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-22 07:55:44

Friday's ETF with Unusual Volume: QQH

The HCM Defender 100 Index ETF is seeing unusually high volume in afternoon trading Friday, with over 190,000 shares traded versus three month average volume of about 26,000. Shares of QQH were up about 0.6% on the day. Components of that ETF with the highest volume on Friday - 2025-09-19 13:23:32

Nasdaq 100 Movers: DXCM, FTNT

In early trading on Friday, shares of Fortinet topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.7%. Year to date, Fortinet has lost about 11.9% of its value. And the worst performing Nasdaq 100 component thus far on the day is DexCo - 2025-09-19 12:11:42

DexCom, Inc. (NASDAQ:DXCM) Receives $99.89 Consensus Price Target from Brokerages

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and three have given a strong buy […] - 2025-09-18 03:01:05

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

When it comes to identifying target stocks for investment, compelling prospects may include companies that are undervalued and, simultaneously, expected to appreciate in the future. Of course, timing an investment in one of these firms is notoriously difficult. It may help to lo - 2025-09-14 11:27:00

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 13:38:14

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:43:18

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 12:13:06

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 10:36:17

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:39:38

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 08:27:13

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-09 06:09:22

DexCom (NASDAQ:DXCM) Downgraded by Oppenheimer to Market Perform

Oppenheimer cut shares of DexCom (NASDAQ:DXCM – Free Report) from an outperform rating to a market perform rating in a research report sent to investors on Monday, MarketBeat.com reports. Other research analysts have also recently issued research reports about the stock. Argus assumed coverage on shares of DexCom in a research report on Thursday, August […] - 2025-09-09 02:50:44

Stocks Settle Higher as Bond Yields Fall and Chip Makers Climb

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.46%. September E-mini S&P futures (ESU25 ) rose +0.25%, and September E-mini Nasdaq futures... - 2025-09-08 22:27:11

DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Analysts

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating on […] - 2025-08-21 02:41:01

Leerink Partnrs Predicts DexCom’s Q3 Earnings (NASDAQ:DXCM)

DexCom, Inc. (NASDAQ:DXCM – Free Report) – Investment analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of DexCom in a report released on Wednesday, July 30th. Leerink Partnrs analyst M. Kratky now expects that the medical device company will post earnings of $0.57 per share for the quarter, down from their […] - 2025-08-04 02:46:55

DexCom (DXCM) Q2 Revenue Jumps 15%

Key PointsRevenue (GAAP) rose 15% year-over-year in Q2 2025, easily surpassing expectations and driven by strong U.S. and international growth. - 2025-08-01 01:53:01

Allianz Asset Management GmbH Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Allianz Asset Management GmbH lowered its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,079 shares of the medical device company’s stock after selling 21,698 shares during the period. Allianz Asset […] - 2025-07-29 04:42:53

DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025. - 2025-07-29 01:00:16

Private Advisor Group LLC Decreases Stock Position in DexCom, Inc. (NASDAQ:DXCM)

Private Advisor Group LLC cut its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 13,461 shares of the medical device company’s stock after selling 1,688 shares during the period. Private Advisor Group LLC’s holdings in DexCom were worth $919,000 as of its most recent […] - 2025-07-28 05:22:58

HighPoint Advisor Group LLC Has $299,000 Holdings in DexCom, Inc. (NASDAQ:DXCM)

HighPoint Advisor Group LLC cut its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,196 shares of the medical device company’s stock after selling 749 shares during the quarter. HighPoint Advisor Group LLC’s […] - 2025-07-24 05:51:13

AVLV's Underlying Holdings Imply 10% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-21 10:15:07

DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Friday. A number of other equities research analysts have also commented on the company. Cfra Research upgraded DexCom to a “hold” rating in a research report on Friday, March […] - 2025-07-21 04:58:50

Morgan Stanley Forecasts Strong Price Appreciation for DexCom (NASDAQ:DXCM) Stock

DexCom (NASDAQ:DXCM – Get Free Report) had its target price increased by equities research analysts at Morgan Stanley from $82.00 to $89.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the medical device company’s stock. Morgan Stanley’s price objective would indicate a potential upside […] - 2025-07-17 06:22:53

Cerity Partners LLC Grows Stock Holdings in DexCom, Inc. (NASDAQ:DXCM)

Cerity Partners LLC grew its holdings in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 4.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,601 shares of the medical device company’s stock after acquiring an additional 2,711 shares during the period. Cerity Partners LLC’s […] - 2025-07-17 05:30:58

DexCom, Inc. (NASDAQ:DXCM) Shares Acquired by Stratos Wealth Partners LTD.

Stratos Wealth Partners LTD. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 32.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,428 shares of the medical device company’s stock after buying an additional 845 shares during the quarter. Stratos […] - 2025-07-17 04:58:54

Allworth Financial LP Purchases 1,765 Shares of DexCom, Inc. (NASDAQ:DXCM)

Allworth Financial LP lifted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 163.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,846 shares of the medical device company’s stock after acquiring an additional 1,765 shares during the period. Allworth Financial LP’s holdings in DexCom were worth $201,000 at the end of […] - 2025-07-16 05:18:51

Nisa Investment Advisors LLC Cuts Stake in DexCom, Inc. (NASDAQ:DXCM)

Nisa Investment Advisors LLC lowered its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 53.9% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,228 shares of the medical device company’s stock after selling 40,004 shares during the quarter. Nisa Investment Advisors […] - 2025-07-14 05:50:57

Principal Financial Group Inc. Boosts Holdings in DexCom, Inc. (NASDAQ:DXCM)

Principal Financial Group Inc. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 804,917 shares of the medical device company’s stock after purchasing an additional 219,965 shares during the […] - 2025-07-07 08:08:45

First Horizon Advisors Inc. Has $108,000 Stock Position in DexCom, Inc. (NASDAQ:DXCM)

First Horizon Advisors Inc. increased its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.4% during the 1st quarter, Holdings Channel.com reports. The fund owned 1,582 shares of the medical device company’s stock after acquiring an additional 320 shares during the period. First Horizon Advisors Inc.’s holdings in DexCom were worth $108,000 […] - 2025-07-07 06:19:27

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) DXCM holdings

Date	Number of DXCM Shares Held	Base Market Value of DXCM Shares	Local Market Value of DXCM Shares	Change in DXCM Shares Held	Change in DXCM Base Value	Current Price per DXCM Share Held	Previous Price per DXCM Share Held
2025-09-25 (Thursday)	120,690	USD 8,243,127	USD 8,243,127
2025-09-24 (Wednesday)	119,767	USD 8,084,273	USD 8,084,273
2025-09-18 (Thursday)	105,026	USD 7,958,870	USD 7,958,870	124	USD -59,839	USD 75.78	USD 76.44
2025-09-17 (Wednesday)	104,902	USD 8,018,709	USD 8,018,709	0	USD -11,539	USD 76.44	USD 76.55
2025-09-16 (Tuesday)	104,902	USD 8,030,248	USD 8,030,248	0	USD 101,755	USD 76.55	USD 75.58
2025-09-15 (Monday)	104,902	USD 7,928,493	USD 7,928,493	0	USD -67,137	USD 75.58	USD 76.22
2025-09-12 (Friday)	104,902	USD 7,995,630	USD 7,995,630
2025-09-10 (Wednesday)	104,902	USD 7,972,552	USD 7,972,552
2025-09-09 (Tuesday)	104,964	USD 8,229,178	USD 8,229,178

Share Trades of DXCM by Blackrock for IE0003WV2ME7

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-09-18	BUY	124			75.780*		79.46
2025-08-18	BUY	114			80.820*		79.51
2025-08-12	SELL	-62			80.170*		79.49 Profit of 4,929 on sale
2025-07-29	BUY	66			89.350*		79.38
2025-07-23	SELL	-186			86.430*		79.25 Profit of 14,740 on sale
2025-07-22	SELL	-372			85.120*		79.21 Profit of 29,467 on sale
2025-07-21	SELL	-124			84.030*		79.19 Profit of 9,819 on sale
2025-07-15	SELL	-124			84.780*		79.13 Profit of 9,812 on sale
2025-07-14	SELL	-310			85.330*		79.09 Profit of 24,519 on sale
2025-07-11	SELL	-186			83.370*		79.07 Profit of 14,707 on sale
2025-07-10	SELL	-744			85.460*		79.03 Profit of 58,800 on sale
2025-07-09	SELL	-248			84.870*		79.00 Profit of 19,592 on sale
2025-07-08	SELL	-806			83.760*		78.97 Profit of 63,650 on sale
2025-07-03	SELL	-1,054			82.930*		78.90 Profit of 83,161 on sale
2025-07-02	SELL	-191			83.580*		78.87 Profit of 15,065 on sale
2025-06-27	SELL	-3,038			86.330*		78.78 Profit of 239,327 on sale
2025-06-25	BUY	62			84.680*		78.70
2025-06-24	SELL	-2,294			87.570*		78.65 Profit of 180,423 on sale
2025-06-23	SELL	-62			79.840*		78.64 Profit of 4,876 on sale
2025-06-20	SELL	-11,779			80.000*		78.63 Profit of 926,235 on sale
2025-06-18	SELL	-408			81.010*		78.60 Profit of 32,071 on sale
2025-06-17	SELL	-759			81.830*		78.58 Profit of 59,646 on sale
2025-06-11	SELL	-207			82.990*		78.53 Profit of 16,256 on sale
2025-06-10	SELL	-483			84.820*		78.49 Profit of 37,910 on sale
2025-06-06	SELL	-138			86.670*		78.39 Profit of 10,818 on sale
2025-06-05	SELL	-1,173			85.740*		78.34 Profit of 91,894 on sale
2025-06-02	SELL	-5,589			85.510*		78.19 Profit of 436,995 on sale
2025-05-30	SELL	-1,224			85.800*		78.14 Profit of 95,640 on sale
2025-05-29	SELL	-136			84.860*		78.09 Profit of 10,621 on sale
2025-05-27	SELL	-136			85.330*		77.98 Profit of 10,605 on sale
2025-05-23	SELL	-204			84.510*		77.89 Profit of 15,890 on sale
2025-05-16	SELL	-1,020			85.480*		77.60 Profit of 79,155 on sale
2025-05-15	SELL	-204			85.670*		77.54 Profit of 15,819 on sale
2025-05-13	SELL	-68			84.110*		77.43 Profit of 5,265 on sale
2025-05-12	SELL	-476			85.050*		77.37 Profit of 36,830 on sale
2025-05-09	SELL	-408			84.670*		77.32 Profit of 31,546 on sale
2025-05-08	SELL	-1,972			85.340*		77.26 Profit of 152,354 on sale
2025-05-07	SELL	-136			83.350*		77.21 Profit of 10,501 on sale
2025-05-06	BUY	56			81.530*		77.18
2025-05-01	BUY	2,584			70.260*		77.17
2025-04-30	BUY	1,428			71.380*		77.22
2025-04-29	SELL	-272			71.300*		77.27 Profit of 21,017 on sale
2025-04-28	SELL	-340			71.180*		77.32 Profit of 26,288 on sale
2025-04-25	BUY	138			71.660*		77.36
2025-04-24	SELL	-69			70.780*		77.42 Profit of 5,342 on sale
2025-04-22	SELL	-9,112			66.330*		77.59 Profit of 707,038 on sale
2025-04-17	SELL	-4,148			68.570*		77.84 Profit of 322,899 on sale
2025-04-16	BUY	136			68.730*		77.92
2025-04-15	BUY	136			69.230*		78.00
2025-04-10	SELL	-4,347			67.300*		78.29 Profit of 340,330 on sale
2025-04-09	BUY	345			66.840*		78.39
2025-04-08	BUY	69			60.690*		78.55
2025-04-07	BUY	1,224			61.630*		78.71
2025-04-04	BUY	748			59.830*		78.88
2025-04-02	BUY	476			68.140*		78.98
2025-04-01	BUY	5,450			67.320*		79.09
2025-03-31	BUY	207			68.290*		79.19
2025-03-25	BUY	69			73.550*		79.52
2025-03-21	BUY	8,661			73.800*		79.62
2025-03-20	BUY	130			75.110*		79.67
2025-03-18	BUY	325			70.700*		79.82
2025-03-17	BUY	45			71.350*		79.91
2025-03-14	SELL	-25			70.690*		80.01 Profit of 2,000 on sale
2025-03-13	SELL	-4,225			68.480*		80.13 Profit of 338,557 on sale
2025-03-12	BUY	780			70.760*		80.23
2025-03-11	BUY	780			70.260*		80.34
2025-03-07	BUY	260			77.840*		80.48
2025-03-06	BUY	910			79.510*		80.49
2025-03-05	BUY	4,940			81.960*		80.47
2025-03-04	BUY	260			82.420*		80.45
2025-03-03	BUY	325			85.990*		80.38
2025-02-28	BUY	650			88.370*		80.29
2025-02-27	BUY	585			87.810*		80.20
2025-02-26	SELL	-340			89.910*		80.08 Profit of 27,228 on sale
2025-02-25	SELL	-65			88.320*		79.98 Profit of 5,199 on sale
2025-02-24	BUY	65			90.750*		79.85
2025-02-20	SELL	-845			89.340*		79.62 Profit of 67,275 on sale
2025-02-19	BUY	260			89.680*		79.49
2025-02-18	BUY	264			90.530*		79.34
2025-02-13	BUY	7,410			84.090*		79.02
2025-02-12	BUY	2,210			83.870*		78.95
2025-02-11	BUY	1,825			86.380*		78.85
2025-02-07	BUY	195			88.080*		78.58
2025-02-06	BUY	2,600			88.320*		78.44
2025-02-05	BUY	1,300			88.780*		78.29
2025-02-04	BUY	975			87.460*		78.15
2025-02-03	SELL	-5,655			87.050*		78.02 Profit of 441,177 on sale
2025-01-31	BUY	520			86.830*		77.88
2025-01-30	BUY	65			87.620*		77.73
2025-01-29	BUY	1,105			86.430*		77.59
2025-01-28	BUY	390			88.350*		77.42
2025-01-27	BUY	390			87.530*		77.25
2025-01-24	BUY	390			88.750*		77.06
2025-01-23	BUY	1,105			87.700*		76.88
2025-01-22	BUY	650			87.090*		76.70
2025-01-21	BUY	3,835			86.320*		76.53
2025-01-17	BUY	780			84.380*		76.25
2025-01-15	BUY	390			80.400*		76.01
2025-01-13	BUY	1,105			79.840*		75.87
2025-01-10	BUY	844			77.760*		75.83
2024-12-31	BUY	195			77.770*		75.55
2024-12-30	BUY	260			78.000*		75.49
2024-12-27	BUY	1,249			80.240*		75.38
2024-12-23	BUY	390			79.540*		75.04
2024-12-20	SELL	-10,448			80.040*		74.91 Profit of 782,696 on sale
2024-12-19	BUY	864			75.820*		74.89
2024-12-17	BUY	652			77.800*		74.80
2024-12-16	BUY	216			76.410*		74.76
2024-12-13	BUY	360			77.190*		74.69
2024-12-11	BUY	216			80.470*		74.52
2024-12-10	BUY	144			79.410*		74.37
2024-12-09	BUY	144			78.410*		74.24
2024-12-05	SELL	-432			78.920*		73.97 Profit of 31,955 on sale
2024-12-04	BUY	73			81.010*		73.73
2024-12-02	BUY	288			79.310*		73.26
2024-11-29	BUY	1,278			77.990*		73.07
2024-11-27	BUY	284			78.100*		72.65
2024-11-26	BUY	710			77.940*		72.42
2024-11-25	BUY	8,804			77.830*		72.18
2024-11-22	BUY	213			72.830*		72.15
2024-11-21	BUY	213			74.460*		72.03
2024-11-20	BUY	923			75.240*		71.86
2024-11-19	SELL	-923			74.880*		71.70 Profit of 66,176 on sale
2024-11-18	BUY	4,260			76.270*		71.43
2024-11-12	BUY	852			74.340*		71.25
2024-11-11	BUY	213			70.310*		71.31
2024-11-08	BUY	856			69.960*		71.40
2024-11-07	BUY	1,444			68.910*		71.60
2024-11-06	BUY	639			68.610*		71.84
2024-11-05	BUY	142			69.000*		72.10
2024-11-04	BUY	735			69.700*		72.34
2024-11-01	BUY	355			70.350*		72.56
2024-10-30	BUY	213			71.800*		72.97
2024-10-29	BUY	1,349			72.240*		73.09
2024-10-25	BUY	284			73.440*		73.26
2024-10-24	BUY	213			74.850*		72.72
2024-10-22	BUY	426			73.080*		72.61
2024-10-21	BUY	355			72.610*		0.00

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DXCM

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer